Corrado Advisors LLC lessened its position in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 25.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 6,630 shares of the company’s stock after selling 2,210 shares during the period. Corrado Advisors LLC’s holdings in BlackRock Health Sciences Trust were worth $251,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Wolverine Asset Management LLC lifted its stake in BlackRock Health Sciences Trust by 42.4% in the third quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock worth $3,588,000 after purchasing an additional 25,457 shares during the last quarter. AlphaStar Capital Management LLC bought a new stake in shares of BlackRock Health Sciences Trust during the 4th quarter worth approximately $878,000. Hara Capital LLC purchased a new position in BlackRock Health Sciences Trust during the 4th quarter valued at $832,000. International Assets Investment Management LLC bought a new position in BlackRock Health Sciences Trust in the 3rd quarter valued at $8,610,000. Finally, Janney Montgomery Scott LLC increased its stake in BlackRock Health Sciences Trust by 40.5% in the fourth quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after purchasing an additional 9,455 shares during the period.
BlackRock Health Sciences Trust Trading Down 0.4 %
NYSE:BME opened at $40.14 on Thursday. BlackRock Health Sciences Trust has a twelve month low of $36.87 and a twelve month high of $42.73. The stock has a fifty day simple moving average of $39.53 and a 200-day simple moving average of $40.40.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Trust
- 3 Stocks to Consider Buying in October
- Buffett’s on the Sidelines – Should You Follow?
- CD Calculator: Certificate of Deposit Calculator
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.